Raiffeisen Bank International’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$26.8M Sell
74,462
-2,634
-3% -$902K 0.31% 75
2026
Q1
$26.9M Buy
77,096
+1,782
+2% +$635K 0.39% 68
2025
Q4
$24.8M Buy
75,314
+137
+0.2% +$43.5K 0.32% 80
2025
Q3
$20.6M Buy
75,177
+4,886
+7% +$1.42M 0.27% 89
2025
Q2
$19.7M Sell
70,291
-13,989
-17% -$3.96M 0.29% 88
2025
Q1
$25.9M Buy
84,280
+3,466
+4% +$1.02M 0.41% 73
2024
Q4
$21M Buy
+80,814
New +$24M 0.32% 82

Other funds holding AMGN

Raiffeisen Bank International's AMGN Position: Q2 2026 in Review

Raiffeisen Bank International reduced its Amgen (AMGN) stake by 3.4% in Q2 2026, selling an estimated $902K and leaving 74,462 shares worth $26.8M. The position accounts for 0.31% of the portfolio, ranked #75.

Raiffeisen Bank International first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. The position peaked at $26.9M in Q1 2026. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Raiffeisen Bank International held 74,462 shares of Amgen worth $26.8M as of Q2 2026.
  • Raiffeisen Bank International sold 2,634 Amgen shares in Q2 2026, an estimated $902K.
  • Amgen made up 0.31% of Raiffeisen Bank International's portfolio in Q2 2026, its #75 holding.
  • Raiffeisen Bank International first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
  • Raiffeisen Bank International's Amgen position peaked at $26.9M in Q1 2026.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Raiffeisen Bank International's 13F filing for Q2 2026, filed 3 Aug 2026.